Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 96951-97000 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03606967
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
PHASE2Recruiting
70 participants
Started: Apr 13, 2021 · Completed: Nov 30, 2025
3 conditions1 sponsor30 locations
NCT04878003
Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis
PHASE2Recruiting
52 participants
Started: Apr 13, 2021 · Completed: Oct 31, 2025
3 conditions1 sponsor29 locations
NCT04903925
Probiotics for Improving Post-surgical Healing
NARecruiting
150 participants
Started: Apr 13, 2021 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT04705480
Pregabalin vs. Gabapentin on Reducing Opioid Usage
PHASE4Recruiting
210 participants
Started: Apr 12, 2021 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT04731155
Impact of Early PCSK9 Inhibitor on Heart After Acute Myocardium Infarction
PHASE4Recruiting
20 participants
Started: Apr 12, 2021 · Completed: Oct 31, 2025
1 condition1 sponsor2 locations
NCT04799912
Labor Induction in Low-risk Nulliparous Women at 39 Weeks of Gestation to Reduce Cesarean: A Randomized Trial of Induction Versus Expectant Management in France (FRENCH-ARRIVE)
NARecruiting
4,200 participants
Started: Apr 12, 2021 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT04971980
Safety and Efficacy Study of Human Umbilical Cord-Derived Mesenchymal Stem Cells(BC-U001) for Rheumatoid Arthritis
PHASE1/PHASE2Active, not recruiting
9 participants
Started: Apr 12, 2021 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT04855435
Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours
PHASE1Recruiting
69 participants
Started: Apr 12, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor5 locations
NCT04519151
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer
PHASE2Recruiting
24 participants
Started: Apr 12, 2021 · Completed: Nov 30, 2029
8 conditions1 sponsor1 location
NCT05044689
Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria
N/ARecruiting
800 participants
Started: Apr 12, 2021 · Completed: Dec 31, 2026
2 conditions7 sponsors1 location
NCT04255966
Plasmafit® Revision Structan® Hip Endoprosthesis Cup
N/AActive, not recruiting
60 participants
Started: Apr 12, 2021 · Completed: Jun 30, 2027
8 conditions1 sponsor4 locations
NCT04838756
Mammography Screening With Artificial Intelligence (MASAI)
NAActive, not recruiting
100,000 participants
Started: Apr 12, 2021 · Completed: May 7, 2025
1 condition3 sponsors1 location
NCT05547061
A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapy
PHASE1/PHASE2Active, not recruiting
91 participants
Started: Apr 12, 2021 · Completed: Dec 31, 2024
2 conditions1 sponsor4 locations
NCT04787783
Evaluation of the Utility of Preanestes@s, a Web Based Application for Preoperative Assessment
NARecruiting
2,254 participants
Started: Apr 12, 2021 · Completed: Jun 30, 2025
4 conditions1 sponsor1 location
NCT04802876
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors
PHASE2Active, not recruiting
184 participants
Started: Apr 12, 2021 · Completed: Mar 31, 2027
31 conditions2 sponsors1 location
NCT04859270
The Holistic Health Care of Post-Cardiac Arrest Survivors: From Patient's Health to Family Resilience
N/ARecruiting
600 participants
Started: Apr 12, 2021 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT04840108
Veteran Support for Smoking Cessation Pilot Project (VAntage Pilot)
NARecruiting
64 participants
Started: Apr 12, 2021 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT03786237
Rigosertib for RDEB-SCC
PHASE1/PHASE2Recruiting
12 participants
Started: Apr 12, 2021 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT04077346
Neuromodulation of Spinal Locomotor Circuitry to Elicit Stepping After Pediatric Spinal Cord Injury
NAEnrolling by invitation
8 participants
Started: Apr 12, 2021 · Completed: Jan 31, 2026
1 condition3 sponsors1 location
NCT04667585
Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx
NARecruiting
120 participants
Started: Apr 12, 2021 · Completed: Jan 31, 2028
1 condition1 sponsor2 locations
NCT07115407
Validation of the POGO Score for Classification of Videolaryngoscopy in Children - Post-hoc Analysis of the PeDiAC Study
N/AActive, not recruiting
809 participants
Started: Apr 12, 2021 · Completed: Aug 31, 2025
4 conditions1 sponsor1 location
NCT04576156
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
PHASE3Recruiting
320 participants
Started: Apr 12, 2021 · Completed: Jun 30, 2028
1 condition1 sponsor220 locations
NCT04722796
HANGZHOU Solution in Bicuspid AS Undergoing TAVR
NARecruiting
508 participants
Started: Apr 12, 2021 · Completed: Apr 1, 2028
2 conditions19 sponsors18 locations
NCT05955664
Evaluation of Diffusion Tensor Imaging and High Frequency 3D Endovaginal Ultrasound
NAActive, not recruiting
20 participants
Started: Apr 12, 2021 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT04791748
Virtual Reality in Children With and Without Vestibular Deficits
NARecruiting
140 participants
Started: Apr 12, 2021 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT04680377
Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients
N/ARecruiting
44 participants
Started: Apr 12, 2021 · Completed: Dec 31, 2026
2 conditions2 sponsors2 locations
NCT04308564
Laboratory and Clinical Data in Antiphospholipid Patients
N/ARecruiting
60 participants
Started: Apr 12, 2021 · Completed: Apr 1, 2031
1 condition1 sponsor2 locations
NCT06317519
Verify the Performance in Clinical Practice of the Immersive Virtual Reality Platform GRAIL (Gait Real-time Analysis Interactive Lab)
N/ARecruiting
100 participants
Started: Apr 12, 2021 · Completed: Apr 12, 2026
2 conditions1 sponsor1 location
NCT04759664
LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC
PHASE2Recruiting
117 participants
Started: Apr 12, 2021 · Completed: May 31, 2024
1 condition1 sponsor20 locations
NCT04571749
Handoffs and Transitions in Critical Care - Understanding Scalability
NAEnrolling by invitation
4,000 participants
Started: Apr 11, 2021 · Completed: Jul 31, 2026
5 conditions3 sponsors5 locations
NCT05568784
Straight Leg Raise Continuation
N/ARecruiting
100 participants
Started: Apr 11, 2021 · Completed: Jul 3, 2024
2 conditions2 sponsors1 location
NCT04847115
Treatment of Fifth Metatarsal Zone 3 Fractures
NARecruiting
100 participants
Started: Apr 10, 2021 · Completed: Mar 31, 2030
2 conditions3 sponsors3 locations
NCT04841668
Gut-Brain-axis: Targets for Improvement of Cognition in the Elderly
N/ARecruiting
136 participants
Started: Apr 10, 2021 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT06848751
Tubeless Surgery With Impaired Pulmonary Function
NARecruiting
30 participants
Started: Apr 10, 2021 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04852068
A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)
PHASE3Active, not recruiting
2,480 participants
Started: Apr 10, 2021 · Completed: Oct 30, 2024
2 conditions1 sponsor1 location
NCT04831528
Decision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical Study
N/ANot yet recruiting
100 participants
Started: Apr 10, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor0 locations
NCT04888338
Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies
N/ARecruiting
100 participants
Started: Apr 10, 2021 · Completed: Nov 14, 2026
1 condition1 sponsor1 location
NCT03806309
OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC
PHASE2Active, not recruiting
106 participants
Started: Apr 10, 2021 · Completed: Dec 31, 2025
3 conditions2 sponsors28 locations
NCT04868396
Patient-derived Glioma Stem Cell Organoids
N/AActive, not recruiting
60 participants
Started: Apr 10, 2021 · Completed: Sep 1, 2025
1 condition1 sponsor2 locations
NCT04460937
Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers
PHASE1Active, not recruiting
4 participants
Started: Apr 9, 2021 · Completed: Dec 18, 2025
59 conditions1 sponsor7 locations
NCT05231915
Prevalence of the c.853delT Mutation of the HOXB13 Gene in Prostate Cancer in Martinique
NARecruiting
465 participants
Started: Apr 9, 2021 · Completed: Apr 9, 2025
1 condition1 sponsor1 location
NCT04869813
Sarcopenia Magnetic Resonance Imaging Evaluation (SUSIE)
N/ARecruiting
70 participants
Started: Apr 9, 2021 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT04858880
Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy.
NARecruiting
374 participants
Started: Apr 9, 2021 · Completed: Apr 30, 2030
1 condition1 sponsor3 locations
NCT04603495
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
PHASE3Active, not recruiting
430 participants
Started: Apr 9, 2021 · Completed: Dec 31, 2027
4 conditions1 sponsor156 locations
NCT05761769
Twin Pregnancy: a Challenge for Patients, Families and Health Professionals
N/ARecruiting
200 participants
Started: Apr 9, 2021 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT04848961
A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer
EARLY_PHASE1Active, not recruiting
30 participants
Started: Apr 9, 2021 · Completed: Apr 9, 2026
1 condition1 sponsor7 locations
NCT04482062
TRISCEND II Pivotal Trial
NAActive, not recruiting
1,070 participants
Started: Apr 9, 2021 · Completed: Jun 27, 2030
6 conditions1 sponsor62 locations
NCT04726748
Economic Evaluation of Prostatic Urethral Lift
N/AActive, not recruiting
1,360 participants
Started: Apr 8, 2021 · Completed: Dec 12, 2025
1 condition2 sponsors6 locations
NCT04585477
Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)
PHASE2Recruiting
80 participants
Started: Apr 8, 2021 · Completed: Dec 30, 2026
4 conditions2 sponsors1 location
NCT04869332
Three Cancellous Screws Versus Four Cancellous Screws for Femoral Neck Fixation
NARecruiting
290 participants
Started: Apr 8, 2021 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location